ArticleTherapeutics and clinical risk management2006
Cost-benefit analysis of influenza vaccination in a public healthcare unit.
Article in Therapeutics and clinical risk management, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.
- Pooled it
- Economic evaluations of occupational health interventions from a company's perspective: a systematic review of methods to estimate the cost of health-related productivity loss.Journal of occupational rehabilitation · 2011Pooled it
- Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive.Human vaccines & immunotherapeutics · 2026Observational
- Intramuscular vs. Subcutaneous: Rethinking Influenza Vaccination Strategy in Japan.JMA journal · 2024Article
- Uptake and correlates of influenza vaccine among older adults residing in rural regions of south China: a cross-sectional study.Frontiers in public health · 2024Article
- Vaccine supply chain coordination using blockchain and artificial intelligence technologies.Computers & industrial engineering · 2023Article
- COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost-Benefit Analysis.International journal of environmental research and public health · 2022Article
- Workplace influenza vaccination in private hospital setting: a cost-benefit analysis.Annals of occupational and environmental medicine · 2022Article
- Review
- Estimated Cost Effectiveness of Influenza Vaccination for Emergency Medical Services Professionals.The western journal of emergency medicine · 2021Article
- A Systematic Review and Meta-Analysis of Seasonal Influenza Vaccination of Health Workers.Vaccines · 2021Review
- Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.Vaccines · 2021Review
- Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks.BMC medicine · 2018Article
- The sustainability of influenza vaccination programs: considerations and perspectives from Italy.Journal of preventive medicine and hygiene · 2016Review
- Economic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysis.PLoS medicine · 2010Article
- Adult Immunization in Occupational Settings: A Consensus of Indian Experts.Indian journal of occupational and environmental medicineReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEstimate the costs and benefits of influenza vaccination in a group of employees of an Italian District Health Authority, Unità Locale Socio Sanitaria (ULSS), to define a scheme of an economic evaluation to be used for other vaccination strategies.
designIn an observational study conducted from December 2002 to April 2003, 107 ULSS employees, voluntarily vaccinated, were compared with 107 nonvaccinated ULSS employees matched for age, sex, and job category. The outcome of cost-benefit analysis was evaluated by checking personnel department records about absences from work and their causes, including influenza. Costs and benefits of the influenza vaccination from the ULSS point of view were calculated.
resultsThe influenza vaccination strategy reduced absences from work by 23% and decreased the loss of working days by 30% and related cost. This difference is not significative. The ratio vaccination benefits/cost was euro4.2. The advantage of vaccination is confirmed by sensitivity analysis performed on the mean cost of a working day, which showed that the benefit-cost ratio ranged from euro4.5 to euro11.7.
conclusionsThe results suggest that the influenza vaccination strategy in our sample of people was cost-saving. The economic evaluation used in this study could also be used for other vaccination strategies and in other settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.